European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries

Launched by UNIVERSITY OF PADOVA · Oct 11, 2023

Keywords

ClinConnect Summary

The European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries (EURO-AAOCA) is a clinical trial that aims to learn more about a rare heart condition called anomalous aortic origin of a coronary artery (AAOCA). This condition is a type of congenital heart defect, meaning it is present at birth, and affects how the arteries that supply blood to the heart are formed. The trial seeks to gather information from different medical centers to understand how patients with AAOCA are treated and managed, which will help improve care for individuals living with this condition.

To participate in this study, individuals must have been diagnosed with AAOCA and may be either undergoing surgery or receiving medical follow-up. However, some types of heart issues, like certain anomalies associated with other major heart defects, are not included in this study. Those who join the trial can expect to contribute to important research that aims to improve the understanding and management of AAOCA, ultimately benefiting future patients. This study is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )
• Exclusion Criteria:
• • isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).